Shingo Eikawa
Okayama, 7008558, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Targeting the αvβ5 Integrin Modifies the TGFβ-Rich Tumor Microenvironment of Pancreatic Cancer.
Journal: Cancer research
Published: September 18, 2025
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
Journal: Nature medicine
Published: December 19, 2024
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer.
Journal: Journal for immunotherapy of cancer
Published: August 04, 2023
Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.
Journal: International immunology
Published: August 08, 2018
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation.
Journal: Scientific reports
Published: January 24, 2018
Metabolic Competition in Tumor Microenvironment
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 16, 2017
Metformin-dependent metabolic reprogramming contributes to efficient anti-tumor immunity.
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: February 01, 2017
Study about the Efficacy of Metformin to Immune Function in Cancer Patients.
Journal: Acta medica Okayama
Published: August 24, 2016
AntiTumor and Immunoregulatory Effects of Fermented Papaya Preparation (FPP: SAIDOPS501).
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: August 12, 2016
Last Updated: 09/26/2026